Regenovue Plus: A Professional Overview for Wholesale Sourcing

Regenovue Plus is a specialized hyaluronic acid (HA) dermal filler originating from South Korea, developed by NeoGenesis Co., Ltd. It is formulated to meet specific requirements within the professional aesthetic market. As a component of a comprehensive HA filler portfolio, Regenovue Plus offers distinct characteristics for various applications.

This product is typically integrated into clinical practices for specific indications, contributing to a diverse range of aesthetic solutions. Understanding its place among other options, such as LEXYAL or UNIONFILL, assists professionals in precise product selection.

Regenovue Plus is composed of cross-linked hyaluronic acid, a fundamental component in many dermal fillers due to its biocompatibility and ability to retain moisture. The manufacturing process by NeoGenesis Co., Ltd. focuses on creating a stable gel consistency suitable for injection.

The specific rheological properties of Regenovue Plus are engineered to facilitate particular aesthetic outcomes. These properties include gel viscosity, cohesivity, and elasticity, which dictate its suitability for different depths of injection and tissue integration. Professionals evaluate these factors to ensure appropriate product placement and desired aesthetic effect.

Aesthetic professionals utilize Regenovue Plus for a range of indications based on its specific formulation. Common areas of professional application include facial contouring, volume augmentation in areas experiencing age-related depletion, and the correction of moderate to deep facial wrinkles and folds.

Effective application requires precise injection techniques and a thorough understanding of facial anatomy. This ensures optimal product distribution and patient outcomes within clinical guidelines. For a broader perspective on HA fillers and their applications, consult our Hyaluronic acid dermal filler catalog.

The perceived duration of aesthetic fillers like Regenovue Plus is influenced by multiple factors, which practitioners communicate transparently to patients. These include the specific cross-linking technology used in the HA formulation, the volume injected, and the injection depth.

Individual patient physiology, such as metabolic rate and lifestyle, also plays a significant role. The anatomical area of injection, characterized by varying levels of muscle movement and blood flow, can further impact how long the product maintains its presence. Professionals consider these variables when planning treatment protocols.

Sourcing genuine Regenovue Plus is critical for maintaining clinic reputation and ensuring patient safety. Professionals must prioritize distributors who provide transparent supply chain information and verify product authenticity. The market for aesthetic injectables, including products like Regenovue Plus, necessitates diligence in procurement to avoid counterfeit or substandard goods.

This principle extends across your entire injectable inventory, as detailed in discussions concerning products like Restylane Defyne: Market Trends and Sourcing for Aesthetic P. Verifiable lot numbers and manufacturer documentation are essential for traceability.

For clinics and professional resellers, wholesale procurement of Regenovue Plus involves understanding pricing tiers and supply logistics. The illustrative wholesale price for Regenovue Plus is $75.8 per unit. This pricing structure often includes volume-based discounts to support larger orders.

Typical volume tiers may offer progressive savings: for example, 11 units could yield a 4% discount, 21 units a 5% discount, 31 units a 6% discount, and orders of 51 units or more could receive an 8% reduction. These structures are designed to provide cost efficiencies for professional buyers managing their inventory, similar to other product lines like Elasty Plus 1CC.